IDEAYA BiosciencesIDYA +5.15%55 Quick Ratio is 10.74 as of Mar. 2026, which is 13% below its 10-year median of 12.39. GuruFocus rates IDYA with a GF Score™ of 55/100 and a GF Value™ of $214.33 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,417 Biotechnology companies, IDEAYA Biosciences ranks better than 80.45% on this metric.
IDEAYA Biosciences has a quick ratio of 10.74. It generally indicates good short-term financial strength.
The historical rank and industry rank for IDEAYA Biosciences's Quick Ratio or its related term are showing as below:
IDYA'
s Quick Ratio Range Over the Past 10 Years
Min: 4.5 Med: 12.39 Max: 28.42
Current: 10.74
During the past 9 years, IDEAYA Biosciences's highest Quick Ratio was 28.42. The lowest was 4.50. And the median was 12.39.
IDYA's Quick Ratio is ranked better than 80.45% of 1417
companies
in the Biotechnology industry
Industry Median: 3.6
vs IDYA: 10.74
IDEAYA Biosciences (NAS:IDYA) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
IDEAYA Biosciences Quick Ratio Related Terms
IDEAYA Biosciences Quick Ratio Historical Data
* Premium members only.
The historical data trend for IDEAYA Biosciences's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, IDEAYA Biosciences's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEAYA Biosciences Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, IDEAYA Biosciences's Quick Ratio distribution charts can be found below:
* The bar in red indicates where IDEAYA Biosciences's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
IDEAYA Biosciences's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDEAYA Biosciences (IDYA) has a Quick Ratio of 10.74 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on IDEAYA Biosciences and its competitors. This is 13% below median its historical median of 12.39. Over the past decade, IDEAYA Biosciences' Quick Ratio has ranged from 4.50 to 28.42. According to the industry distribution chart, IDEAYA Biosciences ranks #277 out of 1417 companies in the Biotechnology industry, placing it in the top 19.5%.
Is IDEAYA Biosciences' Quick Ratio too high?
IDEAYA Biosciences' current Quick Ratio of 10.74 is 13% below median its 10-year median of 12.39. Over the past 10 years, this metric has ranged from a low of 4.50 to a high of 28.42. The Biotechnology industry median Quick Ratio is 3.60. IDEAYA Biosciences' value of 10.74 is 198.3% above this industry median. Based on the distribution chart, IDEAYA Biosciences ranks #277 out of 1417 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, IDEAYA Biosciences has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IDEAYA Biosciences' Quick Ratio compare to MLYS and TARS?
According to the Biotechnology industry distribution chart, IDEAYA Biosciences ranks #277 out of 1417 companies for Quick Ratio. This places IDEAYA Biosciences in the top 20% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 3.60. IDEAYA Biosciences' value of 10.74 is 198.3% above this benchmark. Historically, IDEAYA Biosciences' own Quick Ratio has ranged from 4.50 to 28.42 over the past decade. While the company's 10-year median is 12.39 vs. the industry median of 3.60, IDEAYA Biosciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,417 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IDEAYA Biosciences's current Quick Ratio of 10.74 is 198.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on IDEAYA Biosciences and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDEAYA Biosciences's current Quick Ratio is 10.74, which is 13% below median its own 10-year median of 12.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDEAYA Biosciences stock overvalued right now?
Based on GuruFocus' analysis, IDEAYA Biosciences (IDYA) is currently considered Possible Value Trap. The stock's GF Value™ is $214.33, compared to a current price of $36.67 — trading 82.9% below its estimated fair value. The current Quick Ratio is 10.74, which is 13% below median its 10-year median of 12.39 and 198.3% above the Biotechnology industry median of 3.60. IDEAYA Biosciences' overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For IDEAYA Biosciences (IDYA), the current Quick Ratio is 10.74 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IDEAYA Biosciences (IDYA) Overvalued in 2026?
Based on GuruFocus' analysis, IDEAYA Biosciences stock appears to be undervalued.
The current stock price of $36.67 is trading 82.9% below its estimated GF Value™ of $214.33.
GuruFocus considers IDEAYA Biosciences to be Possible Value Trap.
Key valuation signals for IDYA:
Quick Ratio: 10.74 (13% below median its 10-year median of 12.39)
GF Value™: $214.33 vs. price of $36.67 (82.9% below fair value)
Industry Position: 198.3% above the Biotechnology median (#277 of 1417)
No single metric tells the full story. See the IDYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
55GF Score
Get the complete analysis for IDYA
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IDYA has been successfully added to your 
